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Previewsside,’’ and they help reveal what needs to
be done to understand how they come
back to the light so they can ‘‘overcome
evil’’ and do good.
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Even though proteolytic antigen fragments are displayed for cross-presentation, rapid proteolysis of endo-
cytosed antigens inhibits this process. In this issue of Immunity, Alloatti et al. (2015) describe how maturing
dendritic cells keep phagosomes and lysosomes apart to ensure extended antigen life that leads to pros-
perous cross-presentation.CD8+ T cells, which are considered to
be the protective entity in many virus in-
fections and tumor rejections, recognize
antigen-derived peptides on major his-
tocompatibility complex (MHC) class I
molecules. These peptides are pre-
dominantly generated by proteasomal
degradation from cytosolic and nuclear
antigens. However, if a virus does not
infect dendritic cells (DCs), which prime
these CD8+ T cell responses, or in the
case of tumor antigens that have to be
transferred from the cancer cell to
DCs, it is necessary for CD8+ T cell acti-
vation that extracellular antigens gain
access to the MHC class I presentation
machinery in a pathway called cross-
presentation.
Cross-presentation is best performed
by distinct DC subsets in mouse and
man, and possibly other species, primar-
ily XCR1+ DCs (Vu Manh et al., 2015). In
addition, cross-presentation is transientlymore upregulated during the first day
after DC activation by Toll-like receptor
(TLR) ligands, during the process of
maturation. This transient increase of
cross-presentation is thought to effi-
ciently sample antigen for MHC class I
presentation at the site of DC maturation,
whereas after DCs have then migrated
away towards secondary lymphoid tis-
sues, this mechanism is shut off to pre-
vent cross-presentation of self-antigens
at non-inflamed sites. Such emphasis
on cross-presentation of proteins that
have been taken up in infected and in-
flamed tissues is thought to focus CD8+
T cell priming toward the pathogenic
causes that have elicited DC maturation.
A combination of phagosome and cellular
adaptations are thought to make mature
DCs, especially the XCR1+ DC subset,
particularly efficient antigen cross-pre-
senting cells. Among the phagosome
intrinsic characteristics are the limitedrecruitment of lysosomal proteases to
DC phagosomes (Delamarre et al.,
2005), which allows these antigen-pre-
senting cells to retain endocytosed
material for prolonged periods of time
(Figure 1). Along these lines, DCs also
efficiently recruit the NADPH oxidase
NOX2 to their phagosomes, attenuating
phagosomal acidification via reactive ox-
ygen species production (Savina et al.,
2006). The elevated pH then inhibits
lysosomal hydrolases, which catalyze
substrates most efficiently in an acidic
environment. Apart from attenuating
lysosomal degradation to rescue pep-
tides for MHC loading, cross-presenting
phagosomes have to also acquire the
machinery for MHC class I loading. This
includes MHC class I molecules them-
selves, which are recruited from an endo-
somal recycling compartment to TLR
containing phagosomes (Nair-Gupta
























Figure 1. Regulation of Phagosome Fusion with Lysosomes in Dendritic Cells
Phagosomes in DCs get constitutive input, presumably including components that support MHC class I
loading, from the endoplasmic reticulum (ER) in a Sec22a-dependent manner. Upon TLR ligand
engagement they also recruit MHC class I from early endosomes to phagosomes via SNAP23. These
are in the first 20 hr after TLR ligand encounter stabilized by various mechanisms. They elevate their pH
via reactive oxygen species (ROS) production by NADPH oxidase 2 (NOX2), which is recruited to the
phagosomal membrane. LC3 on the phagosomal membrane blocks fusion with lysosomes. TFEB
regulates lysosomal content via transcription. Finally, as reported by Alloatti and colleagues in this issue
of Immunity, Rab34 sequesters lysosomes in the perinuclear region of DCs to delay their fusion with
phagosomes. This stabilization of phagosomes and their content allows for more efficient cross-pre-
sentation by DCs.
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seems to be at least in part mediated by
the Q-SNARE SNAP23. Other compo-
nents of the MHC class I peptide-loading
complex are delivered from the endo-
plasmic reticulum to cross-presenting
phagosomes via the SNARE binding
protein Sec22b (Cebrian et al., 2011).
Peptide-trimming proteases like the insu-
lin regulated aminopeptidase IRAP are
such additional components that mark
cross-presenting phagosomes (Saveanu
et al., 2009) and thought to generate an-
tigen fragments for optimal MHC class I
loading and cross-presentation to CD8+
T cells. In addition to this regulation of
the cross-presenting phagosome content
in TLR ligand matured DCs, the fusion
of these specialized vesicular com-
partments with lysosomes is strictly
regulated.
In this issue of Immunity, Alloatti and
colleagues demonstrate that lysosomes
are sequestered from phagosomes to
slow down endocytosed cargo degrada-tion in recently matured DCs for better
cross-presentation (Alloatti et al., 2015).
They observed that cross-presentation
of ovalbumin by bone-marrow-derived
DCs increased during the first 16 hr after
exposure to the TLR4 ligand LPS and
then decreased. Furthermore, cross-
presentation by splenic DCs was also
enhanced 16 hr after LPS injection in vivo.
This burst of cross-presentation by re-
cently LPS exposed DCs was associ-
ated with decreased degradation of
phagocytosed cargo, but not with
increased phagocytosis or endosomal
antigen leakage into the cytosol. This pro-
longed endocytosed antigen mainte-
nance seemed to result from delayed
phagosome fusion with lysosomes, re-
cruiting also fewer hydrolases to phago-
somes of LPS treated DCs. In addition,
TLR7 and TLR9 ligands, but not tumor
necrosis factor (TNF)-mediated DC matu-
ration, caused the same decrease in
phagosome fusion with lysosomes. This
decreased degradation of phagocytosedImmunity 43, Decargo was associated with perinuclear
clustering of lysosomes and slower trans-
port of phagosomes to these lysosomes.
The GTPase Rab34 is required for lyso-
somal positioning in macrophages
(Wang and Hong, 2002). Therefore, the
authors RNA silenced Rab34 in LPS
matured DCs and observed that this treat-
ment recovered phagosome fusion with
lysosomes and repositioned lysosomes
after LPS treatment, but not without
maturation. Finally, LPS maturation for
16 hr did not increase cross-presentation
in DCs, which were rendered Rab34 defi-
cient. Therefore, the authors concluded
that shortly after LPS maturation, DCs
reposition their lysosomes to the perinu-
clear area via Rab34 and slow down
phagosome migration toward these lyso-
somes in order to maintain phagocytosed
antigen for improved cross-presentation.
In addition to Rab34-dependent lyso-
some segregation, additional mecha-
nisms have been described that influence
phagocytosed antigen maintenance at
the level of lysosome fusion or composi-
tion in DCs. Transcription factor EB
(TFEB) is a master regulator of lysosomal
function and a number of lysosomal pro-
teases like cathepsins D, L and S are un-
der the direct transcriptional control of
TFEB. It was recently shown that TFEB
gets upregulated after DC maturation by
LPS and that this leads to the shut-down
of cross-presentation 24 hr after DC
maturation (Samie and Cresswell, 2015).
Indeed TFEB overexpression leads to
more rapid degradation of phagocytosed
antigen and its expression after matura-
tion is attenuated in cross-presenting
XCR1+ DCs. Another pathway, by which
phagosome fusion with lysosomes can
be regulated is LC3-associated phagocy-
tosis (LAP). In human monocyte-derived
DCs, the essential autophagy protein
LC3B is recruited to TLR2 ligand-contain-
ing phagosomes (Romao et al., 2013).
Attachment of this protein to the cytosolic
side of the phagosome seems to pre-
vent fusion with lysosomes and confers
prolonged half-life to the respective
phagosomes. This coincides with ineffi-
cient recruitment of the lysosome fusion
machinery to LC3-positive phagosomes.
Only after deconjugation of LC3 do
these phagosomes fuse with lysosomes
for cargo degradation. This mechanism
extends phagosome half-life beyond
30 min, whereas LC3-negativecember 15, 2015 ª2015 Elsevier Inc. 1029
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20 min. Therefore, at least three mecha-
nisms influence TLR ligand containing
antigen maintenance in maturing DCs
at the level of lysosomes. TFEB regu-
lates lysosomal content, LC3 prevents
phagosome fusion with lysosomes and
Rab34 sequesters lysosomes for delayed
fusion with phagosomes, shortly after DC
maturation.
Altogether, the above discussed recent
studies, including the work by Alloatti and
colleagues in this issue of Immunity, have
given us several mechanisms (NOX2,
Rab34, TFEB, and LC3) by which DCs
regulate endocytosed antigen mainte-
nance. A picture is emerging by which
immature DCs cross-present, while
mature DCs upregulate this pathway tran-
siently during the first 20 hr after TLR
ligand exposure and then down-modulate
it. It now needs to be clarified whether all
of these mechanisms are operational at
the same time in the same DC subset,
particularly the proposed professional1030 Immunity 43, December 15, 2015 ª201cross-presenters, the XCR1+ DCs. More-
over we need to determine whether we
can harness the gained knowledge to
render cross-presentation more efficient
during vaccination, where its ability to
prime protective T cell responses has
lagged behind classical antigen process-
ing for MHC class I presentation from re-
combinant viral vectors. Thus, keeping
phagosomes and lysosomes apart might
allow endocytosed antigen, particularly
vaccine formulations, to boldly go where
no one has gone before, namely to
highly efficient cross-presentation on
MHC class I molecules.REFERENCES
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Tissue-residentmemory T (Trm) cells patrol barrier tissues. In this issue of Immunity, Carbone and colleagues
show that downregulation of T-box proteins Eomesodermin and T-bet is critical for their differentiation, but
residual levels of T-bet are important for long-term Trm survival and function.During acute viral infections, virus-spe-
cific CD8+ T cell expansion is coupled
to differentiation pathways resulting in
both effector andmemory T cells. Effector
T cells control the infection but are not
long-lived, whereas memory T cells sur-
vive after the infection, are self-sustaining,
and provide life-long immunity. Extensive
work from many labs has identified pat-
terns of transcription-factor expression
that instruct the development of memory
or effector T cells. For the most part, tran-
scription factors that drive fate decisionsare expressed dichotomously: cells that
have a short half-life express one pattern
and those that will develop into self-sus-
taining memory populations express the
opposite (comprehensively reviewed in
Kaech and Cui, 2012). Perhaps the best
studied of these transcription factors
are the T-box family proteins T-bet and
Eomesodermin (Eomes). High levels of
T-bet are well known to promote effector
differentiation and inhibit memory for-
mation. In contrast, Eomes promotes
memory formation and is critical for thedevelopment and persistence of memory
CD8+ T cell populations. The elegant yin
and yang of this model explains the
formation of long-lived and short-lived
T cells—at least for those T cells found
in circulation and lymphoid tissues after
infection.
It has become apparent in recent years
that circulating and lymphoid-localized
memory T cells comprise only a fraction
of the T cell memory elicited by infections
(Schenkel and Masopust, 2014; Steinert
et al., 2015; Sathaliyawala et al., 2013).
